Reporting model for the implementation of the approved preventive vaccination plans referred to in article 6(2)
| General information |
|---|
| Country | Zoo | Vaccine | Route(specify if different in different species) | Weight — Dose regime used(Actual/estimated/average weight of species) | Vaccine interval | Interval from last vaccination to post-vaccination blood collection |
|---|
| | | | | | |
| HI serum antibody titre |
|---|
| English name/local name | Latin name | Taxonomic Order | Individual identification | VaccineDose (ml) | Pre-vacc | Post-1st vacc | Post-2nd vacc |
|---|
| | | | | | | |
| Adverse Individual effects | Mortality |
|---|
| Local | general | Direct(catching/handling) | Delayed(specify cause of death) |
|---|
| | | |
| Information required from the Laboratory |
|---|
| Virus strain of vaccine | Antigens (virus strains) used in HI test | Cut-off or end-titre point used as a measure of vaccine efficacy | Reference serum used | (reference to)Methodology |
|---|
| | | | |